Aurora Cannabis (ACB) Non Operating Investment Income (2017 - 2022)

Aurora Cannabis (ACB) posted quarterly Non Operating Investment Income of -$1.5 million for Q4 2022, down 130.6% year-on-year from $4.8 million in Q4 2021, and down 10.7% on a QoQ basis from -$1.3 million in Q3 2022.

Aurora Cannabis (ACB) Non Operating Investment Income (2017 - 2022) Analysis & Trends

Aurora Cannabis (ACB) has reported Non Operating Investment Income for 6 consecutive years, with -$1.5 million the latest figure, recorded in Q4 2022.

  • Quarterly Non Operating Investment Income fell 130.6% year-over-year to -$1.5 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$3.1 million (up 62.15% YoY) and the FY2022 annual result came in at -$776138.5, up 93.02% from the prior year.
  • Non Operating Investment Income fell to -$1.5 million in Q4 2022 per ACB's latest filing, from -$1.3 million in the prior quarter.
  • Over the last five years, Non Operating Investment Income for ACB reached as high as $147.2 million in Q4 2018 and fell as low as -$14.5 million in Q3 2019.
  • A 5-year average of $14.1 million and a median of -$748950.7 in 2021 frame the typical range for Non Operating Investment Income.
  • Annual changes were most pronounced in 2018 — Non Operating Investment Income jumped 1111.23% — and 2021, when it sank 205.17%.
  • Year by year, Non Operating Investment Income stood at $147.2 million in 2018, then slumped by 105.91% to -$8.7 million in 2019, then jumped by 40.52% to -$5.2 million in 2020, then soared by 87.65% to -$638635.5 in 2021, then sank by 130.6% to -$1.5 million in 2022.
  • According to Business Quant data, Non Operating Investment Income over the past three periods registered -$1.5 million, -$1.3 million, and -$770222.5 for Q4 2022, Q3 2022, and Q2 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Haleon 89.86 Bn 88.00 Bn - -
2 Teva Pharmaceutical Industries 35.89 Bn 32.15 Bn 1.97 Bn -
3 Zoetis 32.57 Bn 30.63 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.54 Bn 23.48 Bn 4.39 Bn -
5 United Therapeutics 23.06 Bn 20.90 Bn 648.10 Mn -
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.43 Bn 18.62 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.81 Bn 16.49 Bn 800.70 Mn -
9 Elanco Animal Health 12.61 Bn 12.18 Bn 785.00 Mn -
10 Aurora Cannabis 155.11 Mn 69.87 Mn 21.72 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 -1.47 Mn
Dec 31, 2022 -1.47 Mn
Sep 30, 2022 -1.33 Mn
Sep 30, 2022 -1.33 Mn
Jun 30, 2022 -770,222.52
Jun 30, 2022 -770,222.52
Mar 31, 2022 502,106.36
Mar 31, 2022 502,106.36
Dec 31, 2021 -638,635.55
Dec 31, 2021 -638,635.55
Sep 30, 2021 -727,678.93
Sep 30, 2021 -727,678.93
Jun 30, 2021 -7.88 Mn
Jun 30, 2021 -7.88 Mn
Mar 31, 2021 1.13 Mn
Mar 31, 2021 1.13 Mn
Dec 31, 2020 -5.17 Mn
Dec 31, 2020 -5.17 Mn
Sep 30, 2020 691,890.62
Sep 30, 2020 691,890.62